Clinical Trials Logo
  1. Home
  2. Hydroxychloroquine
  3. NCT04340349

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals — ELEVATE  

Hydroxychloroquine Clinical Trial

Official title:
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial)

Clinical Trial Summary

This study will investigate the security and efficacy of a daily low dose of hydroxychloroquine and Bromhexine, in preventing the development of the disease from COVID-19 in Health Care Workers at a National Institute of Health In Mexico City.

Clinical Trial Description

This study will combine two drugs (hydroxychloroquine and Bromhexine) to see if hydroxychloroquine is better in combination with Bromhexine in preventing the development of the disease from COVID-19 in Health Care Workers at a National Institute of Health In Mexico City. Hydroxychloroquine will be used in a low dose (200 mg every 24 hrs). Bromhexine will be 8mg every 8 hrs. The study groups will be the following: 1) HCQ 200mg/d + BHH placebo 2) HCQ placebo plus BHH placebo ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04340349
Study type Interventional
Source Instituto Nacional de Rehabilitacion
Contact
Status Enrolling by invitation
Phase Early Phase 1
Start date February 1, 2021
Completion date June 30, 2021
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04400019 - Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) Phase 2/Phase 3
Completed NCT02942381 - A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy Phase 2
Completed NCT04347798 - IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT
Completed NCT04652648 - Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts Phase 4
Withdrawn NCT04354441 - Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women Phase 2
Completed NCT04434144 - A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
Active, not recruiting NCT04363827 - Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) Phase 2
Completed NCT04376814 - Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 N/A
Completed NCT02648464 - Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial Phase 4
Not yet recruiting NCT05647330 - Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer Phase 2
Withdrawn NCT04349228 - Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals Phase 3
Recruiting NCT04363450 - Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) Phase 3
Not yet recruiting NCT04352946 - HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial Phase 3
Recruiting NCT05451277 - At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring